Expozyme Ltd Accounts






Expozyme Ltd

	Company No. 07128474
		Information for Filing with The Registrar
		31 January 2026

The Director presents his report and the accounts for the year ended 31 January 2026.

Principal activities
The principal activity of the company during the year under review was commission income.




Director

The Director who served at any time during the year was as follows:

H. Arzoumanian









































































The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.

Signed on behalf of the board

H. Arzoumanian
Director
31 October 2026

at	31 January 2026
Company No.		07128474	Notes	2026	2025
				£	£






Current assets

	Debtors			25,016	25,000

	Cash at bank and in hand			134,847	182,058
				159,863	207,058
Creditors: Amount falling due within one year				(542)	(2,481)
Net current assets				159,321	204,577
Total assets less current liabilities				159,321	204,577




Net assets				159,321	204,577

Capital and reserves
	Called up share capital			100	100



	Profit and loss account		5	159,221	204,477

Total equity				159,321	204,577



These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.

For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

All the members have consented to the preparation of abridged financial statements for the year ended 31 January 2026 in accordance with the Companies Act 2006.

As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.

Approved by the board on 31 October 2026 and signed on its behalf by:
H. Arzoumanian
Director
31 October 2026

for the year ended 31 January 2026

General information

Expozyme Ltd is a private company limited by shares and incorporated in England and Wales.

Its registered number is: 07128474

Its registered office is:

4 Whitchurch Parade,

Whitchurch Lane

Edgware

Middlesex

HA8 6LR

The abridged accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006, including the provisions permitting an abridged profit and loss account and balance sheet to be prepared.

Accounting policies

Turnover

Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.

3	Employees
			2026	2025
			Number	Number
		The average monthly number of employees (including directors) during the year was:	1	1

Share Capital

100 Ordinary shares of £1 each

Reserves

Profit and loss account - includes all current and prior period retained profits and losses.

6	Dividends
			2026	2025
			£	£
		Dividends for the period:
		Dividends paid in the period	37,500	38,000

			37,500	38,000

		Dividends by type:

		Equity dividends	37,500	38,000
			37,500	38,000